内非鼻类型持续性动脉静脉可以通过超动脉栓塞或用液体栓塞物质进行静脉穿栓塞来治愈
Yoshikazu Matsuda1, Tomoaki Terada2, Yu Sakamoto2
1Department of Neurosurgery, Showa University Hospital, Tokyo, Japan.
Journal of neuroendovascular therapy
|September 21, 2023
概括
超动脉栓塞 (TAE) 和输静脉栓塞 (TVE) 实现了内非鼻腔长期动脉静脉囊 (NSDAVF) 的高闭塞率. 这些内血管治疗为NSDAVF患者提供了安全有效的选择.
科学领域:
- 神经学 神经学
- 干预性放射学 干预性放射学
- 血管外科 血管外科
背景情况:
- 内非鼻腔持续性动脉静脉 (NSDAVFs) 存在复杂的治疗挑战.
- 栓塞材料和技术的近期进步改善了结果.
研究的目的:
- 在NSDAVFs的内血管治疗中研究导致有利的阻塞率的因素.
- 评估NSDAVFs的跨动脉栓塞 (TAE) 和输静脉栓塞 (TVE) 的疗效和安全性.
主要方法:
- 在2014年至2022年期间治疗的227名内持续性动脉静脉 (DAVF) 患者的回顾性分析.
- 包括38名被诊断患有NSDAVF的患者,他们接受了内血管治疗 (TAE或TVE).
- 临床特征,血管学结果和临床结果的评估.
主要成果:
- 即时血管图形封闭率为84.2% (32/38),6个月后的封闭率为88.5% (31/35).
- 在35名患者中进行过动脉栓塞 (TAE),在3名患者中进行过静脉栓塞 (TVE).
- 三个病例出现并发症,30天没有发病率或死亡率.
结论:
- 使用先进的微导管和微导线技术进行的跨动脉栓塞 (TAE) 对NSDAVFs有效.
- 静脉输血栓塞 (TVE) 对于困难或失败的TAE病例是一个可行的替代方案.
- 内血管治疗,包括TAE和TVE,显示了对内NSDAVFs的高成功率和安全性.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Hemodialysis I: Introduction
39
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
39


